Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5276
Ardelyx
ARDX
$1.22B
| $113K | ﹤0.01% |
24,033
-7,459
| -24% | -$25.9K |
|
5277
Citi Trends
CTRN
$555M
| $113K | ﹤0.01% |
6,208
-1,713
| -22% | -$27.8K |
|
|
GDEN
5278
DELISTED
Golden Entertainment
GDEN
| $113K | ﹤0.01% |
8,500
-3,147
| -27% | -$43.8K |
|
5279
iRadimed
IRMD
$1.16B
| $113K | ﹤0.01% |
5,352
+2,509
| +88% | +$51.2K |
|
|
CLCT
5280
DELISTED
Collectors Universe
CLCT
| $113K | ﹤0.01% |
3,994
-1,169
| -23% | -$28.4K |
|
5281
Amalgamated Financial
AMAL
$1.48B
| $112K | ﹤0.01% |
7,043
-2,174
| -24% | -$35.5K |
|
5282
LCNB Corp
LCNB
$282M
| $112K | ﹤0.01% |
6,336
-1,967
| -24% | -$34.5K |
|
5283
PUT
Waters Corp
WAT
$37B
| $112K | ﹤0.01% |
500
+300
| +150% | +$64.8K |
|
|
GRTS
5284
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $112K | ﹤0.01% |
13,066
-3,193
| -20% | -$32.3K |
|
5285
PUT
Calumet Specialty Products
CLMT
$3.85B
| $111K | ﹤0.01% |
30,600
-3,700
| -11% | -$15.8K |
|
5286
CALL
Canadian Pacific Kansas City
CP
$78.1B
| $111K | ﹤0.01% |
2,500
-215,500
| -99% | -$10.1M |
|
|
ITIC
5287
Investors Title Co
ITIC
$546M
| $111K | ﹤0.01% |
696
-217
| -24% | -$33.6K |
|
5288
Lloyds Banking Group
LYG
$89.5B
| $111K | ﹤0.01% |
42,444
-434,377
| -91% | -$1.13M |
|
5289
RGC Resources
RGCO
$223M
| $111K | ﹤0.01% |
3,816
-1,188
| -24% | -$33.9K |
|
5290
PUT
Silicon Laboratories
SLAB
$7.17B
| $111K | ﹤0.01% |
1,000
-5,400
| -84% | -$585K |
|
5291
Syndax Pharmaceuticals
SNDX
$1.69B
| $111K | ﹤0.01% |
14,944
-2,881
| -16% | -$26.2K |
|
5292
Sportsman's Warehouse
SPWH
$44.5M
| $111K | ﹤0.01% |
21,527
-6,710
| -24% | -$28.9K |
|
5293
Village Super Market
VLGEA
$651M
| $111K | ﹤0.01% |
4,185
-1,305
| -24% | -$33.1K |
|
|
SFE
5294
DELISTED
Safeguard Scientifics, Inc.
SFE
| $111K | ﹤0.01% |
9,838
-2,827
| -22% | -$33.7K |
|
|
HBMD
5295
DELISTED
Howard Bancorp, Inc. Common Stock
HBMD
| $111K | ﹤0.01% |
6,628
-1,967
| -23% | -$29.7K |
|
|
ARD
5296
DELISTED
Ardagh Group S.A. Class A Common Shares
ARD
| $111K | ﹤0.01% |
7,070
-78
| -1% | -$1.34K |
|
|
FCBP
5297
DELISTED
First Choice Bancorp Common Stock
FCBP
| $111K | ﹤0.01% |
5,219
-1,494
| -22% | -$32.4K |
|
|
FLEU
5298
DELISTED
Barclays ETN+ FI Enhanced Europe 50 ETN Series B
FLEU
| $111K | ﹤0.01% |
810
-4,735
| -85% | -$638K |
|
5299
Agios Pharmaceuticals
AGIO
$1.79B
| $110K | ﹤0.01% |
3,389
-77,532
| -96% | -$3.21M |
|
5300
CALL
Direxion Daily MSCI Emerging Markets Bear 3X ETF
EDZ
$18.3M
| $110K | ﹤0.01% |
230
+40
| +21% | +$18.8K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.